Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Gene Therapy
|
June 14, 2000
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers
U Modlich, C W Pugh, R Bicknell
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 1, 1996
Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion
U Modlich, F J Kaup, H G Augustin
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
November 30, 2007
[Gene therapy of SCID-X1]
C Baum, A Schambach, U Modlich, et al.
The American Journal of Pathology
|
August 1, 1995
Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression
H G Augustin, K Braun, I Telemenakis, et al.
Differentiation; Research in Biological Diversity
|
January 19, 2002
Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis
C Mailhos, U Modlich, J Lewis, et al.
Cytogenetic and Genome Research
|
November 7, 2013
Chromosomal instability and telomere shortening in long-term culture of hematopoietic stem cells: insights from a cell culture model of RPS14 haploinsufficiency
K Thomay, A Schienke, B Vajen, et al.
Oncogene
|
August 1, 2012
Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas
S Wolf, C Rudolph, M Morgan, et al.
Gene Therapy
|
May 18, 2012
Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system
N Lachmann, S Brennig, N Pfaff, et al.
Leukemia
|
May 23, 2008
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16
U Modlich, A Schambach, M H Brugman, et al.
Gene Therapy
|
October 7, 2011
MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy
N Lachmann, J Jagielska, D Heckl, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Gene Therapy
|
June 14, 2000
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers
U Modlich, C W Pugh, R Bicknell
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 1, 1996
Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion
U Modlich, F J Kaup, H G Augustin
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
November 30, 2007
[Gene therapy of SCID-X1]
C Baum, A Schambach, U Modlich, et al.
The American Journal of Pathology
|
August 1, 1995
Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression
H G Augustin, K Braun, I Telemenakis, et al.
Differentiation; Research in Biological Diversity
|
January 19, 2002
Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis
C Mailhos, U Modlich, J Lewis, et al.
Cytogenetic and Genome Research
|
November 7, 2013
Chromosomal instability and telomere shortening in long-term culture of hematopoietic stem cells: insights from a cell culture model of RPS14 haploinsufficiency
K Thomay, A Schienke, B Vajen, et al.
Oncogene
|
August 1, 2012
Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas
S Wolf, C Rudolph, M Morgan, et al.
Gene Therapy
|
May 18, 2012
Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system
N Lachmann, S Brennig, N Pfaff, et al.
Leukemia
|
May 23, 2008
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16
U Modlich, A Schambach, M H Brugman, et al.
Gene Therapy
|
October 7, 2011
MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy
N Lachmann, J Jagielska, D Heckl, et al.
Page
of 2